BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1082396)

  • 1. Cell-mediated immunity in patients on long-term haemodialysis.
    Kauffman CA; Manzler AD; Phair JP
    Clin Exp Immunol; 1975 Oct; 22(1):54-61. PubMed ID: 1082396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis.
    Holdsworth SR; Fitzgerald MG; Hosking CS; Atkins RC
    Clin Exp Immunol; 1978 Jul; 33(1):95-101. PubMed ID: 709914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro reactivity of lymphocytes obtained from uraemic patients maintained by heamodialysis.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1975 Aug; 21(2):298-305. PubMed ID: 126831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of selenium supplementation on immune parameters in chronic uraemic patients on haemodialysis.
    Bonomini M; Forster S; De Risio F; Rychly J; Nebe B; Manfrini V; Klinkmann H; Albertazzi A
    Nephrol Dial Transplant; 1995; 10(9):1654-61. PubMed ID: 8559485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.
    van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA
    Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
    Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
    Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.
    Catalona WJ; Tarpley JL; Potvin C; Chretien PB
    Clin Exp Immunol; 1975 Feb; 19(2):327-33. PubMed ID: 1082390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of haemodialysis on immune response.
    Gombos EA; Jefferson DM; Bhat JG
    Proc Eur Dial Transplant Assoc; 1975; 11():367-73. PubMed ID: 1197260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T mediated immunity in patients undergoing periodic hemodialysis.
    Piazza I; Alibrandi F; Semenzato G; Battistella L; Amadori G; Gasparotto G
    Boll Ist Sieroter Milan; 1978 Nov; 57(5):631-6. PubMed ID: 314813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cellular immunity in dialysis patients using the lymphocyte transformation test (LTT) in comparison to conservatively treated patients with chronic terminal renal failure].
    Meissner S; Schwenke H; Witzel E; Achenbach H
    Z Urol Nephrol; 1986 Apr; 79(5):277-86. PubMed ID: 3526744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor cell activity of peripheral mononuclear cells from patients undergoing chronic haemodialysis.
    Guillou PJ; Woodhouse LF; Davison AM; Giles GR
    Biomedicine; 1980 Feb; 32(1):11-7. PubMed ID: 6445213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum.
    Newberry WM; Sanford JP
    J Clin Invest; 1971 Jun; 50(6):1262-71. PubMed ID: 5578233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodialysis, continuous ambulatory peritoneal dialysis and cellular immunity.
    Collart F; Tielemans C; Dratwa M; Schandene L; Wybran J; Dupont E
    Proc Eur Dial Transplant Assoc; 1983; 20():190-4. PubMed ID: 6228939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro analysis of B lymphocyte function in uraemia.
    Degiannis D; Mowat AM; Galloway E; Tsakiris D; Briggs JD; Junor BJ; Parrott DM
    Clin Exp Immunol; 1987 Nov; 70(2):463-70. PubMed ID: 3322618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immunity to nuclear antigens in systemic lupus erythematosus.
    Goldman JA; Litwin A; Adams LE; Krueger RC; Hess EV
    J Clin Invest; 1972 Oct; 51(10):2669-77. PubMed ID: 4560340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of uremia and dialysis on cell-mediated immunity.
    Wojtulewicz-Kurkus J; Klepacka J; Skopińska E; Górski A; Nowaczyk M; Orłowski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):997-1000. PubMed ID: 86344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.